Negative symptoms and therapy strategies in schizophrenia Andrea SchmittPeter Falkai Editorial 29 August 2015 Pages: 541 - 542
Neurobiological background of negative symptoms Silvana GalderisiEleonora MerlottiArmida Mucci Invited Review 24 March 2015 Pages: 543 - 558
Psychometric evaluation of the negative syndrome of schizophrenia Maria Paz Garcia-PortillaLeticia Garcia-AlvarezJulio Bobes Invited Review 24 March 2015 Pages: 559 - 566
Pharmacological treatment of negative symptoms in schizophrenia Hans-Jürgen MöllerPal Czobor Invited Review 21 April 2015 Pages: 567 - 578
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial Yoshiteru TakekitaChiara FabbriAlessandro Serretti Original Paper 28 May 2015 Pages: 579 - 588
Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study Alkomiet HasanClaus Wolff-MenzlerThomas Wobrock Original Paper 26 July 2015 Pages: 589 - 600
Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains Verônica M. Saia-CeredaJuliana S. CassoliDaniel Martins-de-Souza Original Paper 01 August 2015 Pages: 601 - 612
The impact of emotional faces on social motivation in schizophrenia Sina RadkeVera PfersmannBirgit Derntl Original Paper 28 February 2015 Pages: 613 - 622
Influence of empathetic pain processing on cognition in schizophrenia Kesong HuMarijn LijffijtShuchang He Original Paper 05 December 2014 Pages: 623 - 631